Inhibitory neurons that connect and regulate signaling in the brain (interneurons) may contribute to epilepsy and autism in patients with tuberous sclerosis complex.
There is insufficient evidence to support findings, good or bad, for therapies currently used in adolescents and young adults with autism.
A combination of biomarkers may reveal new clues about causes of and potential interventions for autism.
An interdisciplinary team of scientists have successfully tagged a protein that regulates the neurotransmitter serotonin with tiny fluorescent beads, allowing them to track the movements of individual molecules for the first time. This capability makes it possible to study the manner in which serotonin regulates mood, appetite and sleep at a new level of detail.
Identification of brain regions involved in processing sights and sounds may offer insights into disorders like autism and dyslexia.
Vanderbilt University has emerged as one of the nation’s leading academic centers in neuroscience.